Literature DB >> 18514307

Immunoproteomic identification of bovine pericardium xenoantigens.

Leigh G Griffiths1, Leila H Choe, Kenneth F Reardon, Steven W Dow, E Christopher Orton.   

Abstract

Bovine pericardium is an important biomaterial with current application in glutaraldehyde-fixed bioprosthetic heart valves and possible future application as an unfixed biological scaffold for tissue engineering. The importance of both humoral and cell-mediated rejection responses toward fixed and unfixed xenogeneic tissues has become increasingly apparent. However, the full scope and specific identities of bovine pericardium proteins that can elicit an immune response remain largely unknown. In this study, an immunoproteomic approach was used to survey bovine pericardium proteins for their ability to elicit a humoral immune response in rabbits. A two-stage protein extraction protocol was used to separate bovine pericardium proteins into water- and lipid-soluble fractions. Two-dimensional (2-D) gel electrophoresis was performed to separate the proteins from each fraction. Western blots were generated from 2-D gels of both bovine pericardium protein fractions. These blots were probed with serum from rabbits immunized with bovine pericardium and a secondary antibody was used to assess for IgG positivity. Western blots were compared to duplicate 2-D gels and proteins in matched spots were identified by tandem mass spectrometry. Thirty-one putative protein antigens were identified, eight of which are known to be antigenic from previous studies. All of the putative antigens demonstrated progressive staining intensity with increasing days of post-exposure serum. Identified antigenic proteins represented a variety of functional and structural protein types, and included both cellular and matrix proteins. The results of this study have implications for the use of bovine pericardium as a biomaterial in bioprostheses and tissue engineering applications, as well as xenotransplantation in general.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514307      PMCID: PMC2518324          DOI: 10.1016/j.biomaterials.2008.05.006

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  68 in total

1.  Complete dynamic repopulation of decellularized heart valves by application of defined physical signals-an in vitro study.

Authors:  K Schenke-Layland; F Opitz; M Gross; C Döring; K J Halbhuber; F Schirrmeister; Th Wahlers; U A Stock
Journal:  Cardiovasc Res       Date:  2003-12-01       Impact factor: 10.787

2.  Unseen proteome: mining below the tip of the iceberg to find low abundance and membrane proteins.

Authors:  Susanne K Pedersen; Jenny L Harry; Lucille Sebastian; Jasmine Baker; Mathew D Traini; John T McCarthy; Abi Manoharan; Marc R Wilkins; Andrew A Gooley; Pier Giorgio Righetti; Nicolle H Packer; Keith L Williams; Ben R Herbert
Journal:  J Proteome Res       Date:  2003 May-Jun       Impact factor: 4.466

3.  Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves.

Authors:  Marie-Theres Kasimir; Erwin Rieder; Gernot Seebacher; Ernst Wolner; Guenter Weigel; Paul Simon
Journal:  Tissue Eng       Date:  2005 Jul-Aug

Review 4.  Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices.

Authors:  Dörthe Schmidt; Ulrich A Stock; Simon P Hoerstrup
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-08-29       Impact factor: 6.237

5.  Decellularization of bovine pericardium for tissue-engineering by targeted removal of xenoantigens.

Authors:  Ana C Gonçalves; Leigh G Griffiths; Russell V Anthony; E Christopher Orton
Journal:  J Heart Valve Dis       Date:  2005-03

6.  Autoantibodies to peroxiredoxin I and IV in patients with systemic autoimmune diseases.

Authors:  Rie Karasawa; Shoichi Ozaki; Kusuki Nishioka; Tomohiro Kato
Journal:  Microbiol Immunol       Date:  2005       Impact factor: 1.955

7.  The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation.

Authors:  M F O'Brien; S Goldstein; S Walsh; K S Black; R Elkins; D Clarke
Journal:  Semin Thorac Cardiovasc Surg       Date:  1999-10

8.  Relevance of immunologic reactions for tissue failure of bioprosthetic heart valves.

Authors:  M Dahm; M Husmann; D Prüfer; E Groh; H Oelert
Journal:  Ann Thorac Surg       Date:  1995-08       Impact factor: 4.330

9.  Antigen-specific immunomodulation of collagen-induced arthritis with tumor necrosis factor-stimulated dendritic cells.

Authors:  Leonie M van Duivenvoorde; Pascale Louis-Plence; Florence Apparailly; Ellen I H van der Voort; Tom W J Huizinga; Christian Jorgensen; René E M Toes
Journal:  Arthritis Rheum       Date:  2004-10

10.  Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.

Authors:  Ning-Tao Fang; Shang-Zhe Xie; Song-Mei Wang; Hong-Yang Gao; Chun-Gen Wu; Luan-Feng Pan
Journal:  Chin Med J (Engl)       Date:  2007-04-20       Impact factor: 2.628

View more
  20 in total

1.  Pericardial tissue for cardiovascular application: an in-vitro evaluation of established and advanced production processes.

Authors:  L Grefen; F König; M Grab; C Hagl; N Thierfelder
Journal:  J Mater Sci Mater Med       Date:  2018-11-03       Impact factor: 3.896

2.  Proteomic analysis of naturally-sourced biological scaffolds.

Authors:  Qiyao Li; Basak E Uygun; Sharon Geerts; Sinan Ozer; Mark Scalf; Sarah E Gilpin; Harald C Ott; Martin L Yarmush; Lloyd M Smith; Nathan V Welham; Brian L Frey
Journal:  Biomaterials       Date:  2015-10-08       Impact factor: 12.479

3.  Graft-specific immune tolerance is determined by residual antigenicity of xenogeneic extracellular matrix scaffolds.

Authors:  Ailsa J Dalgliesh; Mojtaba Parvizi; Manuela Lopera-Higuita; Jeny Shklover; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2018-08-18       Impact factor: 8.947

4.  Allogeneic human tissue-engineered blood vessel.

Authors:  Clay Quint; Melissa Arief; Akihito Muto; Alan Dardik; Laura E Niklason
Journal:  J Vasc Surg       Date:  2011-11-04       Impact factor: 4.268

5.  In Depth Quantification of Extracellular Matrix Proteins from Human Pancreas.

Authors:  Fengfei Ma; Daniel M Tremmel; Zihui Li; Christopher B Lietz; Sara Dutton Sackett; Jon S Odorico; Lingjun Li
Journal:  J Proteome Res       Date:  2019-07-01       Impact factor: 4.466

Review 6.  Small Diameter Xenogeneic Extracellular Matrix Scaffolds for Vascular Applications.

Authors:  Manuela Lopera Higuita; Leigh G Griffiths
Journal:  Tissue Eng Part B Rev       Date:  2019-11-27       Impact factor: 6.389

7.  Chronic graft-specific cell-mediated immune response toward candidate xenogeneic biomaterial.

Authors:  Katherine V Gates; Leigh G Griffiths
Journal:  Immunol Res       Date:  2018-04       Impact factor: 2.829

Review 8.  Extracellular matrix-based biomaterial scaffolds and the host response.

Authors:  Joseph M Aamodt; David W Grainger
Journal:  Biomaterials       Date:  2016-02-03       Impact factor: 12.479

Review 9.  Immunogenicity in xenogeneic scaffold generation: antigen removal vs. decellularization.

Authors:  Maelene L Wong; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2014-01-31       Impact factor: 8.947

10.  Antigen removal process preserves function of small diameter venous valved conduits, whereas SDS-decellularization results in significant valvular insufficiency.

Authors:  Manuela Lopera Higuita; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2020-03-07       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.